These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 28243911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA, Petäjä J, Griffin JH.
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [Abstract] [Full Text] [Related]

  • 5. Rationale behind the development of low molecular weight heparin derivatives.
    Hirsh J, Ofosu F, Buchanan M.
    Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
    [Abstract] [Full Text] [Related]

  • 6. [Dependence of the anticoagulant activity of starch and inulin on their degree of sulfonation].
    Drozd NN, Torlopov MA, Kuzhim AA, Makarov VA.
    Eksp Klin Farmakol; 2012 Jan; 75(6):31-5. PubMed ID: 22891439
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
    Onishi M, Miyashita Y, Motomura T, Yamashita S, Sakamoto N, Akashi M.
    J Biomater Sci Polym Ed; 1998 Jan; 9(9):973-84. PubMed ID: 9747989
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
    Kalaska B, Sokolowska E, Kaminski K, Szczubialka K, Kramkowski K, Mogielnicki A, Nowakowska M, Buczko W.
    Eur J Pharmacol; 2012 Jul 05; 686(1-3):81-9. PubMed ID: 22579410
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation.
    Fischer AM, Mauzac M, Tapon-Bretaudiere J, Jozefonvicz J.
    Biomaterials; 1985 May 05; 6(3):198-202. PubMed ID: 2408688
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mechanisms of the anticoagulation activity of new semi-synthetic heparinoids].
    Azarova LA, Siatkovskiĭ VA, Kaputskiĭ FN, Torgashov VI.
    Gematol Transfuziol; 1991 Apr 05; 36(4):23-5. PubMed ID: 1712331
    [Abstract] [Full Text] [Related]

  • 14. Effect of dextran sulphates on thrombin activity.
    Suzuki K, Hashimoto S.
    J Clin Pathol; 1979 May 05; 32(5):439-44. PubMed ID: 469001
    [Abstract] [Full Text] [Related]

  • 15. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM, Li L, Zheng BS, Normakhamatov N, Guo SY.
    Int J Biol Macromol; 2007 Oct 01; 41(4):376-82. PubMed ID: 17602735
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA, Pharmacols FB, Cooper J, Horn EH, Rubin PC.
    Methods Find Exp Clin Pharmacol; 2007 Oct 01; 29(8):539-45. PubMed ID: 18040530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.